JP2018518511A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018518511A5 JP2018518511A5 JP2017566839A JP2017566839A JP2018518511A5 JP 2018518511 A5 JP2018518511 A5 JP 2018518511A5 JP 2017566839 A JP2017566839 A JP 2017566839A JP 2017566839 A JP2017566839 A JP 2017566839A JP 2018518511 A5 JP2018518511 A5 JP 2018518511A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- subject
- administration
- immune
- immune response
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562185230P | 2015-06-26 | 2015-06-26 | |
| US62/185,230 | 2015-06-26 | ||
| PCT/EP2016/064613 WO2016207314A2 (en) | 2015-06-26 | 2016-06-23 | Methods of modulating cytosolic dna surveillance molecules |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018518511A JP2018518511A (ja) | 2018-07-12 |
| JP2018518511A5 true JP2018518511A5 (enExample) | 2019-07-18 |
Family
ID=56235815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017566839A Pending JP2018518511A (ja) | 2015-06-26 | 2016-06-23 | 細胞質ｄｎａ監視分子の調節方法 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20190233825A1 (enExample) |
| EP (1) | EP3313376A2 (enExample) |
| JP (1) | JP2018518511A (enExample) |
| KR (1) | KR20180021874A (enExample) |
| CN (1) | CN108472255A (enExample) |
| AR (1) | AR105160A1 (enExample) |
| AU (1) | AU2016282879A1 (enExample) |
| BR (1) | BR112017028121A2 (enExample) |
| CA (1) | CA2990526A1 (enExample) |
| CL (1) | CL2017003373A1 (enExample) |
| CR (1) | CR20180003A (enExample) |
| DO (1) | DOP2017000313A (enExample) |
| HK (1) | HK1256128A1 (enExample) |
| IL (1) | IL256264A (enExample) |
| MX (1) | MX2017017141A (enExample) |
| PE (1) | PE20181208A1 (enExample) |
| PH (1) | PH12017502413A1 (enExample) |
| RU (1) | RU2018102915A (enExample) |
| SG (1) | SG10201913395VA (enExample) |
| TW (1) | TW201710509A (enExample) |
| UY (1) | UY36756A (enExample) |
| WO (1) | WO2016207314A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016081911A2 (en) | 2014-11-21 | 2016-05-26 | Northwestern University | The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates |
| US10933131B2 (en) | 2016-07-26 | 2021-03-02 | Bayer Animal Health Gmbh | Increased fertility in bovine species |
| WO2018039629A2 (en) | 2016-08-25 | 2018-03-01 | Northwestern University | Micellar spherical nucleic acids from thermoresponsive, traceless templates |
| WO2018209270A1 (en) | 2017-05-11 | 2018-11-15 | Northwestern University | Adoptive cell therapy using spherical nucleic acids (snas) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US155950A (en) * | 1874-10-13 | Improvement in hand-saws | ||
| AU713040B2 (en) * | 1994-07-15 | 1999-11-18 | University Of Iowa Research Foundation, The | Immunomodulatory oligonucleotides |
| EP1003531B1 (en) * | 1997-05-20 | 2007-08-22 | Ottawa Health Research Institute | Processes for preparing nucleic acid constructs |
| US6693086B1 (en) * | 1998-06-25 | 2004-02-17 | National Jewish Medical And Research Center | Systemic immune activation method using nucleic acid-lipid complexes |
| AU2001296354A1 (en) * | 2000-09-25 | 2002-04-02 | Baylor College Of Medicine | Improved system for regulation of transgene expression |
| AU2002953015A0 (en) * | 2002-12-02 | 2002-12-12 | Women's And Children's Hospital | Modified lacz gene |
| WO2005033265A2 (en) * | 2003-04-25 | 2005-04-14 | Epimmune Inc. | Optimized multi-epitope constructs and uses thereof |
| PE20050386A1 (es) * | 2003-05-29 | 2005-06-23 | Schering Plough Ltd | Composiciones farmaceuticas de florfenicol |
| JP2008511545A (ja) * | 2004-08-13 | 2008-04-17 | ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア | 抗生物質耐性欠失ｄｎａワクチン |
| ES2543079T3 (es) * | 2004-08-13 | 2015-08-14 | The Trustees Of The University Of Pennsylvania | Métodos para construir vacunas sin resistencia antibiótica |
| CA2761736C (en) * | 2009-05-14 | 2017-09-26 | Bayer Animal Health Gmbh | Enhanced immune response in avian species |
| SI2654785T1 (sl) * | 2010-12-22 | 2019-06-28 | Bayer Intellectual Property Gmbh | Ojačan imunski odziv pri govejih vrstah |
| JP5872684B2 (ja) * | 2011-05-26 | 2016-03-01 | インターベット インターナショナル ベー． フェー． | 免疫刺激性オリゴデオキシヌクレオチド |
| AR091569A1 (es) * | 2012-06-28 | 2015-02-11 | Intervet Int Bv | Receptores de tipo toll |
| CA2940794C (en) * | 2014-02-28 | 2022-05-31 | Bayer Animal Health Gmbh | Immunostimulatory plasmids |
-
2016
- 2016-06-23 AU AU2016282879A patent/AU2016282879A1/en not_active Abandoned
- 2016-06-23 CA CA2990526A patent/CA2990526A1/en not_active Abandoned
- 2016-06-23 CN CN201680049705.XA patent/CN108472255A/zh active Pending
- 2016-06-23 JP JP2017566839A patent/JP2018518511A/ja active Pending
- 2016-06-23 EP EP16732278.3A patent/EP3313376A2/en not_active Withdrawn
- 2016-06-23 PE PE2017002822A patent/PE20181208A1/es unknown
- 2016-06-23 HK HK18115209.5A patent/HK1256128A1/zh unknown
- 2016-06-23 RU RU2018102915A patent/RU2018102915A/ru not_active Application Discontinuation
- 2016-06-23 US US15/738,794 patent/US20190233825A1/en not_active Abandoned
- 2016-06-23 MX MX2017017141A patent/MX2017017141A/es unknown
- 2016-06-23 BR BR112017028121A patent/BR112017028121A2/pt not_active IP Right Cessation
- 2016-06-23 SG SG10201913395VA patent/SG10201913395VA/en unknown
- 2016-06-23 KR KR1020187002687A patent/KR20180021874A/ko not_active Withdrawn
- 2016-06-23 WO PCT/EP2016/064613 patent/WO2016207314A2/en not_active Ceased
- 2016-06-23 CR CR20180003A patent/CR20180003A/es unknown
- 2016-06-24 TW TW105120099A patent/TW201710509A/zh unknown
- 2016-06-27 UY UY0001036756A patent/UY36756A/es not_active Application Discontinuation
- 2016-06-28 AR ARP160101937A patent/AR105160A1/es not_active Application Discontinuation
-
2017
- 2017-12-12 IL IL256264A patent/IL256264A/en unknown
- 2017-12-22 PH PH12017502413A patent/PH12017502413A1/en unknown
- 2017-12-26 CL CL2017003373A patent/CL2017003373A1/es unknown
- 2017-12-26 DO DO2017000313A patent/DOP2017000313A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12161711B2 (en) | Lassa virus vaccine | |
| US20220347100A1 (en) | LIPID NANOPARTICLES FOR DELIVERING mRNA VACCINES | |
| JP7523897B2 (ja) | 呼吸器合胞体ウイルス（ｒｓｖ）ワクチン | |
| JP2017512202A5 (enExample) | ||
| JP4294584B2 (ja) | 核酸ワクチン接種の免疫応答を高めるための方法 | |
| RU2013133730A (ru) | Повышение иммунного отклика у видов крупного рогатого скота | |
| US8673285B2 (en) | Sphingoid polyalkylamine conjugates for vaccination | |
| RU2016138321A (ru) | Иммуностимулирующие плазмиды | |
| IL314906B1 (en) | Coronavirus vaccine | |
| US12331078B2 (en) | Stabilizing mutants of prefusion SARS-CoV-2 (COVID-19) spike protein and improved yeast surface display engineering platform for the same | |
| EP4153224A1 (en) | Coronavirus antigen compositions and their uses | |
| CN116406299A (zh) | 用于递送mRNA疫苗的脂质纳米颗粒 | |
| US20230136960A1 (en) | Novel MRNA-Based COVID-19 Multi-Valent Vaccine and Methods of Scaled Production of the Same | |
| TW201427686A (zh) | 改良之疫苗組成物及使用方法 | |
| RU2018102915A (ru) | Способы модуляции контрольных молекул цитозольной днк | |
| CN121419787A (zh) | 多价流感mRNA疫苗 | |
| AU2017386682A1 (en) | Influenza vaccines | |
| AR105568A1 (es) | Un método para provocar una respuesta inmunitaria en un sujeto receptor de especie porcina | |
| WO2024211625A1 (en) | Hbv gene editing | |
| WO2023218420A1 (en) | Mrna compositions for inducing latent hiv-1 reversal | |
| US20220175909A1 (en) | Influenza vaccine composition based on novel nucleic acid | |
| JP2023550667A (ja) | 免疫刺激性組成物 | |
| JP2026500282A (ja) | インフルエンザウイルス様粒子をコードするｍＲＮＡ | |
| WO2026085256A1 (en) | Lipid nanoparticles and methods of use | |
| WO2025111442A1 (en) | Lipid nanoparticles and methods of use for dna delivery |